Document is current
Any future updates will be listed below
-
Authors
van Leeuwen, Otto B. https://orcid.org/0000-0002-8600-0479
Nasralla, David https://orcid.org/0000-0001-5531-3387
Ceresa, Carlo D. L. https://orcid.org/0000-0002-8702-3744
Dutkowski, Philipp https://orcid.org/0000-0002-3016-604X
Friend, Peter J. https://orcid.org/0000-0003-0841-9685
Oniscu, Gabriel C. https://orcid.org/0000-0003-1714-920X
Porte, Robert J. https://orcid.org/0000-0003-0538-734X
de Meijer, Vincent E. https://orcid.org/0000-0002-7900-5917
,
Faro, Letizia Lo
Alwayn, Ian P. J.
Hessheimer, Amelia J.
Fondevila, Constantino
Monbaliu, Diethard
Pirenne, Jacques
Ölinger, Robert
Line, Pal Dag
Lurje, Georg
- License Information
-
More Information
Article History
First Online: 16 June 2025
Competing interests
: D.N. and C.D.L.C. have received consultancy income from OrganOx for assisting with the design and conduct of previous trials. P.J.F. is a co-founder and shareholder in OrganOx and received consultancy payments as non-executive chief medical officer of the company. R.J.P. has received speaker’s honoraria and travel support paid to the institution by XVIVO and Aferetica. V.E.d.M. has received speaker’s honoraria paid to the institution by Astellas, Chiesi and XVIVO. O.B.v.L., P.D. and G.C.O. declare no competing interests.
